FDA Inspection 1205109 — Reproductive Medicine Associates Of Philadelphia, P.C.
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.C. on May 4, 2023 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Philadelphia, PA (United States)